Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Dillon

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
The American Journal of Gastroenterology|September 1, 2021
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal AdherencePhilippe J Zamor, Ashley Brown, Douglas E Dylla, et al.
Nature Genetics|June 2, 2009
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinAnn K Daly, Peter T Donaldson, Pallav Bhatnagar, et al.
Clinics in Liver Disease|April 6, 2023
Research Priorities for Precision Medicine in NAFLDPaula Iruzubieta, Ramon Bataller, María Teresa Arias-Loste, et al.
Journal of Viral Hepatitis|November 21, 2024
Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016 Ethiopian Demographic and Health SurveyGetahun Molla Kassa, Atsbeha Gebreegziabxier Weldemariam, Saro Abdella Abrahim, et al.
Drug and Alcohol Dependence|June 9, 2016
Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugsAmanda Weir, Allan McLeod, Hamish Innes, et al.
Proteome Science|July 10, 2018
Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver diseaseChristos Spanos, Elaina M Maldonado, Ciarán P Fisher, et al.
Clinical Pharmacology and Therapeutics|January 21, 2019
Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen AllelesPaola Nicoletti, Guruprasad P Aithal, Thomas C Chamberlain, et al.
Proteome Science|February 20, 2018
Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver diseaseChristos Spanos, Elaina M Maldonado, Ciarán P Fisher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist TherapyEvan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
BMJ Open|March 10, 2019
Top research priorities in liver and gallbladder disorders in the UKKurinchi S Gurusamy, Martine Walmsley, Brian R Davidson, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
The American Journal of Gastroenterology|September 1, 2021
High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal AdherencePhilippe J Zamor, Ashley Brown, Douglas E Dylla, et al.
Nature Genetics|June 2, 2009
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinAnn K Daly, Peter T Donaldson, Pallav Bhatnagar, et al.
Clinics in Liver Disease|April 6, 2023
Research Priorities for Precision Medicine in NAFLDPaula Iruzubieta, Ramon Bataller, María Teresa Arias-Loste, et al.
Journal of Viral Hepatitis|November 21, 2024
Seroprevalence of Hepatitis C in Ethiopia: First National Study Based on the 2016 Ethiopian Demographic and Health SurveyGetahun Molla Kassa, Atsbeha Gebreegziabxier Weldemariam, Saro Abdella Abrahim, et al.
Drug and Alcohol Dependence|June 9, 2016
Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugsAmanda Weir, Allan McLeod, Hamish Innes, et al.
Proteome Science|July 10, 2018
Correction to: Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver diseaseChristos Spanos, Elaina M Maldonado, Ciarán P Fisher, et al.
Clinical Pharmacology and Therapeutics|January 21, 2019
Drug-Induced Liver Injury due to Flucloxacillin: Relevance of Multiple Human Leukocyte Antigen AllelesPaola Nicoletti, Guruprasad P Aithal, Thomas C Chamberlain, et al.
Proteome Science|February 20, 2018
Proteomic identification and characterization of hepatic glyoxalase 1 dysregulation in non-alcoholic fatty liver diseaseChristos Spanos, Elaina M Maldonado, Ciarán P Fisher, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 3, 2019
Adherence to Once-daily and Twice-daily Direct-acting Antiviral Therapy for Hepatitis C Infection Among People With Recent Injection Drug Use or Current Opioid Agonist TherapyEvan B Cunningham, Behzad Hajarizadeh, Janaki Amin, et al.
BMJ Open|March 10, 2019
Top research priorities in liver and gallbladder disorders in the UKKurinchi S Gurusamy, Martine Walmsley, Brian R Davidson, et al.
Pageof 18